Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Front Cardiovasc Med · 2022 · PMC9222127 · PMID 35757326

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our study, assessment of fibrosis by cardiac magnetic resonance showed a trend in regression of myocardial fibrosis in 18.8% of patients, without a significant difference between the groups.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

In our study, there was a trend of improved VO 2 in the G-CSF group at 12 months, but it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.